Intravitreal bevacizumab in pigmented rabbit eyes: histological analysis 90 days after injection

Related authors

• João Carlos Diniz Arraes
• Roberto Carlos Tedesco
• Tatiana Azevedo Arraes
• Elilson Batista da Silva
• Alexandre Ventura
• Marcos Pereira de Ávila

Related articles

• Profile of patients treated with intravitreal antiangiogenics in a Brazilian public service with high level of complexity
• Switch to aflibercept in the treatment of neovascular age-related macular degeneration: 30-month results
• Age-related macular degeneration: a review of current therapies and new treatments
• Macular thickness measured via optic coherence tomography in healthy adults aged 45 years and older: The Brazilian Amazon Region Eye Survey
• Prospective evaluation of the effectiveness of combined treatment of macular edema secondary to retinal vein occlusion with intravitreal bevacizumab and dexamethasone implants
• Antiangiogenic activity of photobiomodulation in experimental model using chorioallantoic embryonic membrane of chicken eggs
• Is there a relationship between the first-day results of anti-VEGF therapy for macular edema due to vascular diseases and longterm outcomes?
• Benzoporphyrin (verteporfin) photodynamic therapy for choroidal neovascularization in age-related macular degeneration
• Ganglion cell layer thinning in diabetic patients without retinopathy: related or unrelated to total macular thickness?
• Baseline predictors of short-term visual outcomes after intravitreal conbercept injection for neovascular age-related macular degeneration

Click here to search